Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
281,834,475
-
Share change
-
+2,695,102
-
Total reported value
-
$12,033,172,248
-
Put/Call ratio
-
80%
-
Price per share
-
$42.68
-
Number of holders
-
800
-
Value change
-
+$121,566,391
-
Number of buys
-
341
-
Number of sells
-
348
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q3 2019
As of 30 Sep 2019,
GLAXOSMITHKLINE PLC - ADR (GSK) was held by
800 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
281,834,475 shares.
The largest 10 holders included
Dodge & Cox, FMR LLC, RENAISSANCE TECHNOLOGIES LLC, Fisher Asset Management, LLC, PRICE T ROWE ASSOCIATES INC /MD/, ROYAL BANK OF CANADA, STATE STREET CORP, Black Creek Investment Management Inc., BANK OF AMERICA CORP /DE/, and HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC.
This page lists
800
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.